← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2021Last known activity
Dec 5, 2025
Timeline
2020s
- Jun 1, 2020
Longbio Pharma— Founded
Drugs by trial phase (4 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (10)
- NCT07266155Lead sponsorPhase 2Dec 5, 2025
- NCT07148557Lead sponsorPhase 1/Phase 2Aug 31, 2025
- NCT06604949Lead sponsorPhase 1Nov 30, 2024
- NCT07212426Lead sponsorPhase 2Nov 14, 2024
- NCT07291284Lead sponsorPhase 3Aug 1, 2024
- NCT06228560Lead sponsorPhase 2Jan 25, 2024
- NCT06294301Lead sponsorPhase 1Nov 19, 2023
- NCT06046391Lead sponsorPhase 2Jul 6, 2023
- NCT06294275Lead sponsorPhase 1Sep 16, 2022
- NCT06294288Lead sponsorPhase 1Jul 1, 2021
Details
- Founded
- Shanghai, CN Jun 1, 2020
- Last known activity
- Dec 5, 2025